Isavuconazole is an advanced treatment for invasive aspergillosis & mucormycosis, especially in adults. Highly effective for these severe fungal infections! #NCLEX #NAPLEX #KAPS #OPRA #Pharmacy #Antifungals #Isavuconazole

Isavuconazole is an advanced treatment for invasive aspergillosis & mucormycosis, especially in adults. Highly effective for these severe fungal infections! #NCLEX #NAPLEX #KAPS #OPRA #Pharmacy #Antifungals #Isavuconazole

European Study of Cerebral #Aspergillosis treated with #Isavuconazole (ESCAI): A study by the ESCMID Fungal Infection Study Group (EFISG) academic.oup.com/cid/article-ab…

Isavuconazole shows promise in treating cerebral aspergillosis with similar mortality rates to voriconazole and good tolerability! 🧠💊 #MedicalResearch #InfectiousDiseases #Aspergillosis #Isavuconazole #Voriconazole #CAStudy #HealthScience

#infectiousdiseases, #meningitis, #cryptococcosis, #immunosuppressed, #immunosuppressed, #isavuconazole

Lower blood levels of #isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring Matteo Bassetti academic.oup.com/jac/advance-ar…

PK/PD modeling and simulation of the in vitro activity of the combinations of #isavuconazole with #echinocandins against #Candida auris - CPT: Pharmacometrics & Systems Pharmacology ascpt.onlinelibrary.wiley.com/doi/10.1002/ps… CanBIO.ehu UPV/EHU

Fungal breakthrough #isavuconazole ppx in Clinical Transplantation study 106 pt heme malignancy - Incidence 17.9% - Of those half 🪦 - ⬆️than other studies, but no exact controls Serum levels were ☑️&👌 Added by Aneela Majeed to "Heme-onc prophylaxis" folder transplantid.net/FYU8GVAY

#HighlyCited 📑Therapeutic #Drug #Monitoring of #Isavuconazole: Serum Concentration Variability and Success Rates for Reaching Target in Comparison with #Voriconazole 📝 by René Jørgensen, Malene Risum, Marie Helleberg et al. Statens Serum Institut 🔗mdpi.com/2079-6382/10/5…

🔎 "Synergistic In Vitro Interaction of #Isavuconazole and #Isoquercitrin against #𝘊𝘢𝘯𝘥𝘪𝘥𝘢 #𝘨𝘭𝘢𝘣𝘳𝘢𝘵𝘢" ⁉️ 🧑‍🔬Synergy was found for all strains when the results were interpreted by the fractional inhibitory concentration index. Read more here: mdpi.com/2309-608X/8/5/…

📢📢High #Variability in #Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider #Pharmacokinetic and #Pharmacodynamic Targets and Breakpoints 👇👇 link.springer.com/article/10.100…

Early attainment of #isavuconazole target concentration using increased loading dose (i.e. 400 mg) in critically ill patients with #ECMO 👉doi.org/10.1093/jac/dk…

#Mucormycosis is a serious #infection and needs to be treated with #prescription #antifungal #medicine, usually #amphotericin B, #posaconazole, or #isavuconazole. These #medicines are given through #oral route or #intravenous route #MedTwitter #HealthForAll #Healthcare

hot off the press: Clinical and demographic factors affecting trough levels of isavuconazole in critically ill patients with or without COVID‐19. Study led by scientists Klinikum Nürnberg and Paracelsus Medizinische Privatuniversität (PMU). #aspergillosis #isavuconazole #tdm 🔓 onlinelibrary.wiley.com/journal/143905…

🔝📢 👉 The aim of this study was to describe the use of #isavuconazole as a salvage therapy in a chronic pulmonary #fungal disease setting with a high prevalence of #azole resistance. 🔎 Read more about the methods and conclusions here: mdpi.com/2309-608X/8/4/…

Isavuconazole, a novel triazole antifungal agent, demonstrates comparable efficacy to other antifungals for treating and preventing invasive fungal infections. It also shows a lower incidence of drug-related adverse events and discontinuations. #Antifungal #Isavuconazole

#Isavuconazole was effective in treating and preventing invasive #fungalinfections and was associated with fewer drug-related #adverseevents and discontinuations than other antifungal agents. ➡️ fal.cn/3zNN6

📢🧪 #Isavuconazole, a second-generation broad-spectrum triazole with activity against yeasts, dimorphic fungi, and molds, has a favorable safety profile and predictable pharmacokinetics. ❔❓ Find out more about this topic from this review, below: mdpi.com/2309-608X/6/4/…

Late entry summarizing a talk from #ECCMID that I think #idtwitter will find of interest: Large retrospective study of #Isavuconazole for CNS #aspergillosis, from EFISG and presented by Alexandra Serris

Thanks for the breakdown spot Ilan Schwartz MD PhD Great to see some published data on #isavuconazole for #coccidioides #coccidiomycosis #idtwitter #MedTwitter #MedEd #TwitteRx